AIMC Topic: Drug Discovery

Clear Filters Showing 1191 to 1200 of 1689 articles

QFlow lite dataset: A machine-learning approach to the charge states in quantum dot experiments.

PloS one
BACKGROUND: Over the past decade, machine learning techniques have revolutionized how research and science are done, from designing new materials and predicting their properties to data mining and analysis to assisting drug discovery to advancing cyb...

Protein Family-Specific Models Using Deep Neural Networks and Transfer Learning Improve Virtual Screening and Highlight the Need for More Data.

Journal of chemical information and modeling
Machine learning has shown enormous potential for computer-aided drug discovery. Here we show how modern convolutional neural networks (CNNs) can be applied to structure-based virtual screening. We have coupled our densely connected CNN (DenseNet) wi...

Deep learning and virtual drug screening.

Future medicinal chemistry
Current drug development is still costly and slow given tremendous technological advancements in drug discovery and medicinal chemistry. Using machine learning (ML) to virtually screen compound libraries promises to fix this for generating drug leads...

Artificial Intelligence in Drug Design.

Molecules (Basel, Switzerland)
Artificial Intelligence (AI) plays a pivotal role in drug discovery. In particular artificial neural networks such as deep neural networks or recurrent networks drive this area. Numerous applications in property or activity predictions like physicoch...

Data Curation can Improve the Prediction Accuracy of Metabolic Intrinsic Clearance.

Molecular informatics
A key consideration at the screening stages of drug discovery is in vitro metabolic stability, often measured in human liver microsomes. Computational prediction models can be built using a large quantity of experimental data available from public da...

Deep learning-based transcriptome data classification for drug-target interaction prediction.

BMC genomics
BACKGROUND: The ability to predict the interaction of drugs with target proteins is essential to research and development of drug. However, the traditional experimental paradigm is costly, and previous in silico prediction paradigms have been impeded...

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.

Molecular pharmaceutics
Modern computational approaches and machine learning techniques accelerate the invention of new drugs. Generative models can discover novel molecular structures within hours, while conventional drug discovery pipelines require months of work. In this...

Deep Learning in Drug Discovery and Medicine; Scratching the Surface.

Molecules (Basel, Switzerland)
The practice of medicine is ever evolving. Diagnosing disease, which is often the first step in a cure, has seen a sea change from the discerning hands of the neighborhood physician to the use of sophisticated machines to use of information gleaned f...

Discovering Highly Potent Molecules from an Initial Set of Inactives Using Iterative Screening.

Journal of chemical information and modeling
The versatility of similarity searching and quantitative structure-activity relationships to model the activity of compound sets within given bioactivity ranges (i.e., interpolation) is well established. However, their relative performance in the com...